The European Commission on Friday granted a conditional marketing authorisation (CMA) for the COVID-19 vaccine developed by multinational pharmaceutical company AstraZeneca. "Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID-19 vaccine developed by AstraZeneca, the third COVID-19 vaccine authorised in the EU," the European Commission said in a statement.from IndiaTV: Google News Feed https://ift.tt/3razVPX
Post a Comment